CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Research and development	$ 20,393	$ 6,839
General and administrative	10,470	3,001
Total operating expenses	30,863	9,840
Loss from operations	(30,863)	(9,840)
Total other income (loss), net:
Interest income	505	457
Other income (loss), net	(565)	44
Net loss	$ (30,923)	$ (9,339)
Net loss per share — basic and diluted	$ (0.50)	$ (4.21)
Weighted-average common shares outstanding — basic and diluted	62,193,734	2,215,958
Comprehensive loss:
Net loss	$ (30,923)	$ (9,339)
Other comprehensive income, net of tax:
Unrealized gain on available-for-sale securities	42	176
Foreign currency translation adjustment	83
Total other comprehensive income	125	176
Comprehensive loss	$ (30,798)	$ (9,163)